Compton Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,969
| Closed | -$259K | – | 63 |
|
|
2022
Q4 | $259K | Sell |
1,969
-180
| -8% | -$23.3K | 0.19% | 66 |
|
|
2022
Q3 | $251K | Sell |
2,149
-100
| -4% | -$12.4K | 0.17% | 70 |
|
|
2022
Q2 | $265K | Sell |
2,249
-700
| -24% | -$83.1K | 0.15% | 82 |
|
|
2022
Q1 | $384K | Sell |
2,949
-75
| -2% | -$9.77K | 0.11% | 128 |
|
|
2021
Q4 | $462K | Buy |
3,024
+75
| +3% | +$11.6K | 0.12% | 124 |
|
|
2021
Q3 | $477K | Sell |
2,949
-90
| -3% | -$15.1K | 0.14% | 112 |
|
|
2021
Q2 | $497K | Sell |
3,039
-210
| -6% | -$32.3K | 0.15% | 110 |
|
|
2021
Q1 | $489K | Hold |
3,249
| – | – | 0.15% | 109 |
|
|
2020
Q4 | $492K | Sell |
3,249
-50
| -2% | -$7.15K | 0.17% | 93 |
|
|
2020
Q3 | $447K | Sell |
3,299
-330
| -9% | -$44.8K | 0.17% | 90 |
|
|
2020
Q2 | $496K | Sell |
3,629
-175
| -5% | -$22.3K | 0.21% | 81 |
|
|
2020
Q1 | $410K | Sell |
3,804
-200
| -5% | -$23K | 0.2% | 83 |
|
|
2019
Q4 | $483K | Hold |
4,004
| – | – | 0.19% | 92 |
|
|
2019
Q3 | $398K | Sell |
4,004
-300
| -7% | -$31.4K | 0.17% | 98 |
|
|
2019
Q2 | $470K | Sell |
4,304
-100
| -2% | -$10.6K | 0.2% | 95 |
|
|
2019
Q1 | $492K | Sell |
4,404
-150
| -3% | -$16.5K | 0.21% | 95 |
|
|
2018
Q4 | $439K | Sell |
4,554
-265
| -5% | -$28.1K | 0.21% | 100 |
|
|
2018
Q3 | $588K | Sell |
4,819
-150
| -3% | -$17.7K | 0.23% | 94 |
|
|
2018
Q2 | $546K | Sell |
4,969
-150
| -3% | -$16K | 0.23% | 95 |
|
|
2018
Q1 | $546K | Sell |
5,119
-170
| -3% | -$18.8K | 0.23% | 98 |
|
|
2017
Q4 | $565K | Sell |
5,289
-120
| -2% | -$12.8K | 0.24% | 96 |
|
|
2017
Q3 | $601K | Sell |
5,409
-405
| -7% | -$43.3K | 0.27% | 90 |
|
|
2017
Q2 | $601K | Buy |
5,814
+285
| +5% | +$28.1K | 0.27% | 87 |
|
|
2017
Q1 | $540K | Buy |
5,529
+525
| +10% | +$50.3K | 0.27% | 86 |
|
|
2016
Q4 | $443K | Sell |
5,004
-4,614
| -48% | -$420K | 0.23% | 92 |
|
|
2016
Q3 | $877K | Buy |
9,618
+4,809
| +100% | +$457K | 0.24% | 88 |
|
|
2016
Q2 | $413K | Hold |
4,809
| – | – | 0.23% | 92 |
|
|
2016
Q1 | $418K | Buy |
4,809
+105
| +2% | +$9.39K | 0.23% | 89 |
|
|
2015
Q4 | $531K | Buy |
4,704
+300
| +7% | +$32.6K | 0.3% | 77 |
|
|
2015
Q3 | $445K | Sell |
4,404
-210
| -5% | -$25.2K | 0.16% | 81 |
|
|
2015
Q2 | $567K | Buy |
+4,614
| New | +$552K | 0.31% | 76 |
|
Other funds holding IBB
Compton Capital Management's IBB Position: Q1 2023 in Review
Compton Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 1,969 shares — an estimated $259K sold.
Compton Capital Management first reported a position in IBB in Q2 2015 and held it in 31 quarters. The position peaked at $877K in Q3 2016. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- Compton Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
- Compton Capital Management sold 1,969 iShares Biotechnology ETF shares in Q1 2023, an estimated $259K.
- Compton Capital Management first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 31 quarters.
- Compton Capital Management's iShares Biotechnology ETF position peaked at $877K in Q3 2016.
- 867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on Compton Capital Management's 13F filing for Q1 2023, filed 9 May 2023.